Adds another claimed state-of-the-art entrant to the crowded AI drug-discovery race.
Geodesic Intelligence, founded by a former ByteDance AI scientist, released NovaAtom-Lite, a life-sciences AI model, claiming it outperforms state-of-the-art systems in AI-driven drug discovery.
Read it at South China Morning Post →